ArticleCureus2025
A Case of Extensive Thromboembolism as a First Presentation of a Pheochromocytoma: Pathophysiologic Insights and Strategic Surgical Intervention.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pheochromocytomas are rare and often underdiagnosed neuroendocrine tumors characterized by excessive catecholamine production, typically presenting in the fourth to fifth decades of life. While the classic presentation includes labile hypertension and a triad of headaches, palpitations, and sweating, thromboembolism as an initial manifestation of pheochromocytoma is exceedingly rare. In this case report, a 78-year-old male patient with cardiovascular risk factors initially presented with a clinical picture consistent with acute coronary syndrome. However, further clinical workup revealed extensive bilateral pulmonary emboli and an incidental adrenal mass. Subsequent biochemical testing and metaiodobenzylguanidine (MIBG) scintigraphy confirmed the diagnosis of pheochromocytoma. A concurrent thromboembolic workup revealed an underlying protein S deficiency. The patient was managed medically with alpha- and beta-adrenergic blockade. Following hemodynamic stabilization, the patient underwent successful laparoscopic adrenalectomy. Postoperative follow-up demonstrated complete resolution of symptoms and near normalization of biochemical markers. In this report, the pathogenesis of thromboembolism in pheochromocytoma is discussed, highlighting both the clinical features and the sophisticated surgical approach to this complex disorder.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.